Project Grant R21AR085741
Award Date
5/1/25
Completion Date
1/31/27
Dollars Obligated
$216K
Federal Grant Program
93.846
Assistance Type
Project Grant
Place of Performance
New York, NY 10016, USA
Similar Awards
This federal Project Grant award R01AR084694, totaling $788,508.00, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The award supports research to understand the mechanisms linking cutaneous photosensitivity and systemic autoimmunity in systemic lupus erythematosus (SLE), with a focus on the role of Langerhans cells and dermal lymphatic regulation. Key...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), aims to develop a novel therapeutic approach for treating systemic lupus erythematosus (SLE). The $115,414 award to the Beckman Research Institute of the City of Hope will fund research to determine if knockdown of the long isoform of the prolactin receptor (LFPRLR) can eradicate pathogenic plasma...
This Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), provides $375,100 to The Johns Hopkins University to conduct a 2-year research study on the interplay between nucleic-acid-dependent phase separation and immune responses against the enzyme cGAS (cyclic GMP-AMP synthase) in systemic lupus erythematosus (SLE). The research aims to determine how...
This $194,700 federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA 93.846 will support research by Boston Children's Hospital to characterize the biological basis and behavioral outcomes of cognitive dysfunction in childhood-onset systemic lupus erythematosus (cSLE). The 2-year study aims to investigate functional brain properties, white matter microstructure, and choroid plexus volume associated with cognitive...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under CFDA program 93.846 Arthritis, Musculoskeletal and Skin Diseases Research provides $715,957 to support research into the mechanisms by which type I interferon promotes the expansion of T peripheral helper (Tph) cells in patients with systemic lupus erythematosus (SLE). The 5-year project, which runs from March 2025 through February 2030, will apply cutting-edge...
This Project Grant award, with a total funding amount of $405,350.00, was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant supports research to characterize lipid droplets in macrophage subsets and determine if targeted modulation of lipid droplets can shift macrophage function in the context of systemic lupus erythematosus (SLE). The research aims to...
This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to study the role of the aryl hydrocarbon receptor (AhR) pathway in suppressing T-bet+ B cells in systemic lupus erythematosus (SLE). The $555,774 award will be used to investigate two key questions: 1) whether IL-4 acts through the AhR pathway to inhibit the development of double negative 2 (DN2) B cells, and 2) how...
The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) awarded The Medical University of South Carolina (MUSC) a $365,420 Project Grant under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846) to study the role of the SLE causal variant NCF1.PR90H in promoting kidney damage. The 2-year project aims to investigate how this genetic variant impacts the function of the NADPH oxidase complex and contributes to systemic lupus erythematosus...
This federal Project Grant award from the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846), totaling $599,693, supports research focused on elucidating molecular pathways and mechanisms that regulate myeloid cell function and osteoclastogenesis under pathological inflammatory conditions, with the goal of developing new therapeutic approaches to suppress pathological bone...
This federal Project Grant award of $147,400.00 was provided by the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) under the Arthritis, Musculoskeletal and Skin Diseases Research program (CFDA 93.846). The grant will fund research at Yale University to investigate how antigen non-related CD4+ T lymphocytes contribute to the pathogenesis of skin fibrosis in systemic sclerosis (scleroderma) and graft-versus-host disease. The research aims to characterize bystander...